

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | presynaptic membrane assembly (GO:0097105) | 5.32009280 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.28727862 |
| 3 | nucleobase catabolic process (GO:0046113) | 5.22715525 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.21500523 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.11499917 |
| 6 | presynaptic membrane organization (GO:0097090) | 4.95754571 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.78535375 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.59833793 |
| 9 | layer formation in cerebral cortex (GO:0021819) | 4.55512142 |
| 10 | vocalization behavior (GO:0071625) | 4.45696926 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.39215498 |
| 12 | synaptic vesicle exocytosis (GO:0016079) | 4.26457173 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.18829549 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.10794586 |
| 15 | exploration behavior (GO:0035640) | 4.01905545 |
| 16 | glutamate secretion (GO:0014047) | 4.00406054 |
| 17 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.98361307 |
| 18 | neuron cell-cell adhesion (GO:0007158) | 3.94909007 |
| 19 | protein localization to synapse (GO:0035418) | 3.94798335 |
| 20 | regulation of synapse structural plasticity (GO:0051823) | 3.91116684 |
| 21 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.88320892 |
| 22 | dendritic spine morphogenesis (GO:0060997) | 3.85825941 |
| 23 | proline transport (GO:0015824) | 3.79830054 |
| 24 | * dendrite morphogenesis (GO:0048813) | 3.76273197 |
| 25 | cellular potassium ion homeostasis (GO:0030007) | 3.74030841 |
| 26 | sodium ion export (GO:0071436) | 3.73729881 |
| 27 | central nervous system neuron axonogenesis (GO:0021955) | 3.72429009 |
| 28 | neurotransmitter secretion (GO:0007269) | 3.71803436 |
| 29 | establishment of mitochondrion localization (GO:0051654) | 3.67375771 |
| 30 | gamma-aminobutyric acid transport (GO:0015812) | 3.64670694 |
| 31 | axonal fasciculation (GO:0007413) | 3.58972691 |
| 32 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.58833647 |
| 33 | regulation of synaptic vesicle transport (GO:1902803) | 3.58685732 |
| 34 | neuron recognition (GO:0008038) | 3.57019816 |
| 35 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.55936993 |
| 36 | positive regulation of synapse assembly (GO:0051965) | 3.53690793 |
| 37 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.53390650 |
| 38 | glutamate receptor signaling pathway (GO:0007215) | 3.52958836 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.52499510 |
| 40 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.47259448 |
| 41 | synaptic transmission, glutamatergic (GO:0035249) | 3.45796314 |
| 42 | activation of protein kinase A activity (GO:0034199) | 3.42483651 |
| 43 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.32740712 |
| 44 | cell communication by electrical coupling (GO:0010644) | 3.30807611 |
| 45 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.26875679 |
| 46 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.26485978 |
| 47 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.25307235 |
| 48 | long-term memory (GO:0007616) | 3.25260752 |
| 49 | regulation of synapse assembly (GO:0051963) | 3.23995052 |
| 50 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.22366800 |
| 51 | positive regulation of synapse maturation (GO:0090129) | 3.22127558 |
| 52 | cell migration in hindbrain (GO:0021535) | 3.21420469 |
| 53 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.19551662 |
| 54 | neuromuscular process controlling balance (GO:0050885) | 3.17631842 |
| 55 | neuron-neuron synaptic transmission (GO:0007270) | 3.16939853 |
| 56 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.12862418 |
| 57 | regulation of ARF protein signal transduction (GO:0032012) | 3.10890846 |
| 58 | axon extension (GO:0048675) | 3.09237940 |
| 59 | prepulse inhibition (GO:0060134) | 3.08289741 |
| 60 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.08071622 |
| 61 | vesicle transport along microtubule (GO:0047496) | 3.06472135 |
| 62 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.05653101 |
| 63 | mechanosensory behavior (GO:0007638) | 3.05566578 |
| 64 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.04968362 |
| 65 | membrane assembly (GO:0071709) | 3.03675685 |
| 66 | limb bud formation (GO:0060174) | 3.02730556 |
| 67 | establishment of nucleus localization (GO:0040023) | 3.00434486 |
| 68 | positive regulation of membrane potential (GO:0045838) | 2.99980834 |
| 69 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.98921078 |
| 70 | mitochondrion transport along microtubule (GO:0047497) | 2.98921078 |
| 71 | neuronal action potential propagation (GO:0019227) | 2.98103071 |
| 72 | transmission of nerve impulse (GO:0019226) | 2.96288302 |
| 73 | response to auditory stimulus (GO:0010996) | 2.96068388 |
| 74 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.95988092 |
| 75 | regulation of axon guidance (GO:1902667) | 2.95350550 |
| 76 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.95266794 |
| 77 | neurotransmitter transport (GO:0006836) | 2.95014188 |
| 78 | negative regulation of dendrite development (GO:2000171) | 2.94761520 |
| 79 | regulation of postsynaptic membrane potential (GO:0060078) | 2.93684159 |
| 80 | clathrin coat assembly (GO:0048268) | 2.92343553 |
| 81 | auditory behavior (GO:0031223) | 2.92258583 |
| 82 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.90012721 |
| 83 | startle response (GO:0001964) | 2.89668920 |
| 84 | organelle transport along microtubule (GO:0072384) | 2.89648116 |
| 85 | innervation (GO:0060384) | 2.88982370 |
| 86 | alanine transport (GO:0032328) | 2.87273516 |
| 87 | synaptic vesicle endocytosis (GO:0048488) | 2.87120426 |
| 88 | axonogenesis (GO:0007409) | 2.86089085 |
| 89 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.84070434 |
| 90 | membrane depolarization during action potential (GO:0086010) | 2.83251002 |
| 91 | glycosphingolipid biosynthetic process (GO:0006688) | 2.82781711 |
| 92 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.82686529 |
| 93 | postsynaptic membrane organization (GO:0001941) | 2.82641142 |
| 94 | neuronal ion channel clustering (GO:0045161) | 2.82476556 |
| 95 | neural tube formation (GO:0001841) | 2.82318979 |
| 96 | retinal ganglion cell axon guidance (GO:0031290) | 2.82175528 |
| 97 | dendrite development (GO:0016358) | 2.81575031 |
| 98 | cerebellar granule cell differentiation (GO:0021707) | 2.80540029 |
| 99 | regulation of synaptic plasticity (GO:0048167) | 2.78671503 |
| 100 | cerebellar Purkinje cell layer development (GO:0021680) | 2.78477552 |
| 101 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.78409005 |
| 102 | potassium ion import (GO:0010107) | 2.77317391 |
| 103 | synapse assembly (GO:0007416) | 2.76709474 |
| 104 | regulation of synapse organization (GO:0050807) | 2.75579298 |
| 105 | cellular sodium ion homeostasis (GO:0006883) | 2.74958884 |
| 106 | glycine transport (GO:0015816) | 2.74653760 |
| 107 | regulation of neurotransmitter secretion (GO:0046928) | 2.73349208 |
| 108 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.72396478 |
| 109 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.72396478 |
| 110 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.72396478 |
| 111 | regulation of neurotransmitter levels (GO:0001505) | 2.72355722 |
| 112 | cardiac ventricle formation (GO:0003211) | 2.72209805 |
| 113 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.71227333 |
| 114 | neurofilament cytoskeleton organization (GO:0060052) | 2.71211760 |
| 115 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.69700793 |
| 116 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.69567331 |
| 117 | regulation of vesicle fusion (GO:0031338) | 2.67912880 |
| 118 | synapse organization (GO:0050808) | 2.67509535 |
| 119 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.67213716 |
| 120 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.67011393 |
| 121 | neuronal action potential (GO:0019228) | 2.66146339 |
| 122 | hippocampus development (GO:0021766) | 2.65831414 |
| 123 | regulation of dendritic spine development (GO:0060998) | 2.65643903 |
| 124 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.64616209 |
| 125 | mating behavior (GO:0007617) | 2.64571806 |
| 126 | positive regulation of dendritic spine development (GO:0060999) | 2.64177113 |
| 127 | neuron projection extension (GO:1990138) | 2.64115896 |
| 128 | membrane hyperpolarization (GO:0060081) | 2.63128233 |
| 129 | potassium ion homeostasis (GO:0055075) | 2.62633046 |
| 130 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.62435578 |
| 131 | long-term synaptic potentiation (GO:0060291) | 2.61983371 |
| 132 | dopamine receptor signaling pathway (GO:0007212) | 2.61158253 |
| 133 | membrane depolarization (GO:0051899) | 2.61068288 |
| 134 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.60921852 |
| 135 | cell communication involved in cardiac conduction (GO:0086065) | 2.60185937 |
| 136 | cardiac chamber formation (GO:0003207) | 2.59687548 |
| 137 | axon cargo transport (GO:0008088) | 2.59614280 |
| 138 | cerebral cortex cell migration (GO:0021795) | 2.59301977 |
| 139 | dendritic spine organization (GO:0097061) | 2.58861188 |
| 140 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.58822333 |
| 141 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.56819580 |
| 142 | neuron migration (GO:0001764) | 2.56799455 |
| 143 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.55432482 |
| 144 | adult walking behavior (GO:0007628) | 2.55336251 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.94638774 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.06468779 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.70810787 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.67891729 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.56155703 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.54839341 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.40261508 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.40261508 |
| 9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.29305013 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.29024271 |
| 11 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.26705810 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.25198241 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.25003281 |
| 14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.24263321 |
| 15 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.22058884 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.20017467 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.19291778 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.14610422 |
| 19 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.07320182 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.01955551 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.98489851 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.97394217 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.95394345 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.95089005 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.93202909 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.91027297 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.82524706 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.81752055 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75152437 |
| 30 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.73259392 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.69579798 |
| 32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.69320084 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.64674338 |
| 34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.62675065 |
| 35 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.60911047 |
| 36 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.60283709 |
| 37 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.56441843 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.55990783 |
| 39 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.55412972 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52180771 |
| 41 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50865883 |
| 42 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.50865883 |
| 43 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49946600 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.44892510 |
| 45 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.43359090 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.43025916 |
| 47 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.39942280 |
| 48 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38273250 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36886257 |
| 50 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.36018607 |
| 51 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.34521745 |
| 52 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.33375175 |
| 53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32367339 |
| 54 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.31240160 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29907030 |
| 56 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.29821386 |
| 57 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.28750978 |
| 58 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.28243850 |
| 59 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.28181895 |
| 60 | * AR_19668381_ChIP-Seq_PC3_Human | 1.27583825 |
| 61 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27429929 |
| 62 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26185089 |
| 63 | EWS_26573619_Chip-Seq_HEK293_Human | 1.25174569 |
| 64 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25087876 |
| 65 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.24901693 |
| 66 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24884645 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24251739 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24176900 |
| 69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23979182 |
| 70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22690070 |
| 71 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21490018 |
| 72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.19928399 |
| 73 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19374579 |
| 74 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.19345443 |
| 75 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.17923356 |
| 76 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.17124401 |
| 77 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16844073 |
| 78 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.16454225 |
| 79 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.16454225 |
| 80 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.16161467 |
| 81 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.15800395 |
| 82 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15604844 |
| 83 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.14688288 |
| 84 | P300_19829295_ChIP-Seq_ESCs_Human | 1.14482327 |
| 85 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.14472456 |
| 86 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14100625 |
| 87 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.14043743 |
| 88 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.13849664 |
| 89 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13403257 |
| 90 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13403257 |
| 91 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12618627 |
| 92 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12315123 |
| 93 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12056400 |
| 94 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11964069 |
| 95 | VDR_22108803_ChIP-Seq_LS180_Human | 1.11957879 |
| 96 | KDM2B_26808549_Chip-Seq_REH_Human | 1.11579956 |
| 97 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10580301 |
| 98 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09527834 |
| 99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08484007 |
| 100 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08298913 |
| 101 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06691865 |
| 102 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.06289500 |
| 103 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06271397 |
| 104 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.03581069 |
| 105 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02447417 |
| 106 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00719241 |
| 107 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.99116845 |
| 108 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98847783 |
| 109 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.98401747 |
| 110 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.96579490 |
| 111 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.95689188 |
| 112 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95568115 |
| 113 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95425979 |
| 114 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94715424 |
| 115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94674895 |
| 116 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.94320397 |
| 117 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93649076 |
| 118 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.93607192 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93204714 |
| 120 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92690144 |
| 121 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92610806 |
| 122 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92372902 |
| 123 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.89717778 |
| 124 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89049738 |
| 125 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.88338561 |
| 126 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88183014 |
| 127 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88086690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.15871717 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.86392498 |
| 3 | MP0004270_analgesia | 3.74352725 |
| 4 | MP0003880_abnormal_central_pattern | 3.62832468 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.10046144 |
| 6 | MP0005423_abnormal_somatic_nervous | 2.94674664 |
| 7 | MP0009745_abnormal_behavioral_response | 2.91963508 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 2.82746800 |
| 9 | MP0009046_muscle_twitch | 2.77689395 |
| 10 | MP0002064_seizures | 2.75332021 |
| 11 | MP0000569_abnormal_digit_pigmentation | 2.60103973 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.54022195 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.46380438 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.44790389 |
| 15 | MP0001486_abnormal_startle_reflex | 2.31301490 |
| 16 | MP0002909_abnormal_adrenal_gland | 2.30218289 |
| 17 | MP0000778_abnormal_nervous_system | 2.20447416 |
| 18 | MP0004858_abnormal_nervous_system | 2.14633560 |
| 19 | MP0002822_catalepsy | 2.13442189 |
| 20 | MP0002272_abnormal_nervous_system | 2.09084924 |
| 21 | MP0003329_amyloid_beta_deposits | 2.00676706 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.96042886 |
| 23 | MP0002735_abnormal_chemical_nociception | 1.94967346 |
| 24 | MP0001440_abnormal_grooming_behavior | 1.91902975 |
| 25 | MP0004885_abnormal_endolymph | 1.89986724 |
| 26 | MP0008569_lethality_at_weaning | 1.88577910 |
| 27 | MP0002184_abnormal_innervation | 1.88194315 |
| 28 | MP0004811_abnormal_neuron_physiology | 1.83736264 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.80700339 |
| 30 | MP0001970_abnormal_pain_threshold | 1.74773975 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.74645101 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.70563087 |
| 33 | MP0004924_abnormal_behavior | 1.70563087 |
| 34 | MP0002736_abnormal_nociception_after | 1.69056276 |
| 35 | MP0000955_abnormal_spinal_cord | 1.68979825 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.68977359 |
| 37 | MP0003121_genomic_imprinting | 1.67061231 |
| 38 | MP0003787_abnormal_imprinting | 1.66605652 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.54521202 |
| 40 | MP0001188_hyperpigmentation | 1.49227151 |
| 41 | MP0001984_abnormal_olfaction | 1.46763604 |
| 42 | * MP0002882_abnormal_neuron_morphology | 1.46019724 |
| 43 | MP0002102_abnormal_ear_morphology | 1.45667259 |
| 44 | MP0003633_abnormal_nervous_system | 1.37965215 |
| 45 | MP0002638_abnormal_pupillary_reflex | 1.34862126 |
| 46 | MP0002066_abnormal_motor_capabilities/c | 1.34083125 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.33662366 |
| 48 | MP0003283_abnormal_digestive_organ | 1.32878158 |
| 49 | MP0002751_abnormal_autonomic_nervous | 1.32339116 |
| 50 | MP0006276_abnormal_autonomic_nervous | 1.29448657 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.28466269 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.25423461 |
| 53 | MP0001299_abnormal_eye_distance/ | 1.25208803 |
| 54 | MP0003690_abnormal_glial_cell | 1.23718250 |
| 55 | MP0002152_abnormal_brain_morphology | 1.19209424 |
| 56 | MP0003879_abnormal_hair_cell | 1.18737192 |
| 57 | MP0003634_abnormal_glial_cell | 1.16213943 |
| 58 | MP0003631_nervous_system_phenotype | 1.16005429 |
| 59 | MP0000751_myopathy | 1.15322060 |
| 60 | MP0003890_abnormal_embryonic-extraembry | 1.08364951 |
| 61 | MP0005248_abnormal_Harderian_gland | 1.07539438 |
| 62 | MP0003122_maternal_imprinting | 1.05400980 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.05149253 |
| 64 | MP0000604_amyloidosis | 1.04146465 |
| 65 | MP0002229_neurodegeneration | 1.02642021 |
| 66 | MP0005187_abnormal_penis_morphology | 1.02488910 |
| 67 | MP0005253_abnormal_eye_physiology | 1.01716099 |
| 68 | MP0008789_abnormal_olfactory_epithelium | 1.01447695 |
| 69 | MP0005551_abnormal_eye_electrophysiolog | 0.99071176 |
| 70 | MP0001177_atelectasis | 0.98986988 |
| 71 | MP0000013_abnormal_adipose_tissue | 0.98145089 |
| 72 | MP0003632_abnormal_nervous_system | 0.96960053 |
| 73 | MP0002090_abnormal_vision | 0.95356556 |
| 74 | MP0004130_abnormal_muscle_cell | 0.95348637 |
| 75 | MP0004133_heterotaxia | 0.95210435 |
| 76 | MP0002069_abnormal_eating/drinking_beha | 0.94130284 |
| 77 | MP0004233_abnormal_muscle_weight | 0.92514244 |
| 78 | MP0005409_darkened_coat_color | 0.92150218 |
| 79 | MP0003385_abnormal_body_wall | 0.91007464 |
| 80 | MP0004085_abnormal_heartbeat | 0.89459550 |
| 81 | MP0000920_abnormal_myelination | 0.87723500 |
| 82 | MP0004043_abnormal_pH_regulation | 0.87368635 |
| 83 | MP0010386_abnormal_urinary_bladder | 0.86879753 |
| 84 | MP0000631_abnormal_neuroendocrine_gland | 0.86473632 |
| 85 | MP0004742_abnormal_vestibular_system | 0.84367511 |
| 86 | MP0002081_perinatal_lethality | 0.83586697 |
| 87 | MP0003119_abnormal_digestive_system | 0.83581723 |
| 88 | MP0010234_abnormal_vibrissa_follicle | 0.81563187 |
| 89 | MP0002233_abnormal_nose_morphology | 0.81477472 |
| 90 | MP0001905_abnormal_dopamine_level | 0.79962190 |
| 91 | MP0004145_abnormal_muscle_electrophysio | 0.79066931 |
| 92 | MP0005535_abnormal_body_temperature | 0.77978086 |
| 93 | MP0004142_abnormal_muscle_tone | 0.77022042 |
| 94 | MP0003045_fibrosis | 0.75457119 |
| 95 | MP0003137_abnormal_impulse_conducting | 0.74858098 |
| 96 | MP0003075_altered_response_to | 0.72068310 |
| 97 | MP0000049_abnormal_middle_ear | 0.71898489 |
| 98 | MP0002752_abnormal_somatic_nervous | 0.71107266 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.70613417 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70547839 |
| 101 | MP0010768_mortality/aging | 0.70393716 |
| 102 | MP0003938_abnormal_ear_development | 0.70164300 |
| 103 | MP0003935_abnormal_craniofacial_develop | 0.69812880 |
| 104 | MP0000462_abnormal_digestive_system | 0.69806250 |
| 105 | MP0004215_abnormal_myocardial_fiber | 0.68866491 |
| 106 | MP0003937_abnormal_limbs/digits/tail_de | 0.67722478 |
| 107 | MP0005195_abnormal_posterior_eye | 0.67132640 |
| 108 | MP0000026_abnormal_inner_ear | 0.66724939 |
| 109 | MP0003861_abnormal_nervous_system | 0.65747457 |
| 110 | MP0008874_decreased_physiological_sensi | 0.65290739 |
| 111 | MP0008877_abnormal_DNA_methylation | 0.65240215 |
| 112 | MP0002089_abnormal_postnatal_growth/wei | 0.63683863 |
| 113 | MP0006072_abnormal_retinal_apoptosis | 0.63326211 |
| 114 | MP0005623_abnormal_meninges_morphology | 0.62744959 |
| 115 | MP0002837_dystrophic_cardiac_calcinosis | 0.61327069 |
| 116 | MP0001963_abnormal_hearing_physiology | 0.60069729 |
| 117 | MP0002234_abnormal_pharynx_morphology | 0.59712016 |
| 118 | MP0001943_abnormal_respiration | 0.58054531 |
| 119 | MP0005394_taste/olfaction_phenotype | 0.58017237 |
| 120 | MP0005499_abnormal_olfactory_system | 0.58017237 |
| 121 | MP0010769_abnormal_survival | 0.57339489 |
| 122 | MP0000534_abnormal_ureter_morphology | 0.56486346 |
| 123 | MP0010770_preweaning_lethality | 0.55773525 |
| 124 | MP0002082_postnatal_lethality | 0.55773525 |
| 125 | MP0001529_abnormal_vocalization | 0.55117826 |
| 126 | MP0001348_abnormal_lacrimal_gland | 0.54453710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.01561147 |
| 2 | Myokymia (HP:0002411) | 4.98170955 |
| 3 | Focal seizures (HP:0007359) | 4.54928269 |
| 4 | Visual hallucinations (HP:0002367) | 4.04980633 |
| 5 | Supranuclear gaze palsy (HP:0000605) | 3.76910758 |
| 6 | Action tremor (HP:0002345) | 3.75335779 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 3.66576650 |
| 8 | Epileptic encephalopathy (HP:0200134) | 3.66356147 |
| 9 | Ankle clonus (HP:0011448) | 3.28722456 |
| 10 | Febrile seizures (HP:0002373) | 3.14508623 |
| 11 | Mutism (HP:0002300) | 3.10673491 |
| 12 | Absence seizures (HP:0002121) | 3.08558271 |
| 13 | Atonic seizures (HP:0010819) | 3.08403022 |
| 14 | Papilledema (HP:0001085) | 3.04980835 |
| 15 | Drooling (HP:0002307) | 2.99021665 |
| 16 | Excessive salivation (HP:0003781) | 2.99021665 |
| 17 | Genetic anticipation (HP:0003743) | 2.95677594 |
| 18 | Cortical dysplasia (HP:0002539) | 2.92801440 |
| 19 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.91103461 |
| 20 | Protruding tongue (HP:0010808) | 2.90857219 |
| 21 | Generalized tonic-clonic seizures (HP:0002069) | 2.90611528 |
| 22 | Papillary thyroid carcinoma (HP:0002895) | 2.89032864 |
| 23 | Neurofibrillary tangles (HP:0002185) | 2.87253956 |
| 24 | Broad-based gait (HP:0002136) | 2.86107231 |
| 25 | Truncal ataxia (HP:0002078) | 2.83950397 |
| 26 | Depression (HP:0000716) | 2.81043411 |
| 27 | Megalencephaly (HP:0001355) | 2.80842324 |
| 28 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.80008219 |
| 29 | Poor eye contact (HP:0000817) | 2.78218207 |
| 30 | Impaired social interactions (HP:0000735) | 2.76072772 |
| 31 | Abnormal social behavior (HP:0012433) | 2.76072772 |
| 32 | Cerebral inclusion bodies (HP:0100314) | 2.75468988 |
| 33 | Dialeptic seizures (HP:0011146) | 2.73927602 |
| 34 | Macroorchidism (HP:0000053) | 2.68206939 |
| 35 | Urinary urgency (HP:0000012) | 2.67973498 |
| 36 | Hepatoblastoma (HP:0002884) | 2.66979000 |
| 37 | Insidious onset (HP:0003587) | 2.66669537 |
| 38 | Termporal pattern (HP:0011008) | 2.66669537 |
| 39 | Abnormality of the corticospinal tract (HP:0002492) | 2.66585681 |
| 40 | Dysdiadochokinesis (HP:0002075) | 2.61959515 |
| 41 | Abnormal eating behavior (HP:0100738) | 2.61883867 |
| 42 | Lissencephaly (HP:0001339) | 2.58188842 |
| 43 | Hemiparesis (HP:0001269) | 2.56937875 |
| 44 | Pachygyria (HP:0001302) | 2.56568605 |
| 45 | Postural instability (HP:0002172) | 2.54732925 |
| 46 | Progressive inability to walk (HP:0002505) | 2.51352387 |
| 47 | Spastic gait (HP:0002064) | 2.48737076 |
| 48 | Abnormality of the lower motor neuron (HP:0002366) | 2.48170913 |
| 49 | Agitation (HP:0000713) | 2.47317448 |
| 50 | Abnormality of binocular vision (HP:0011514) | 2.47053468 |
| 51 | Diplopia (HP:0000651) | 2.47053468 |
| 52 | Intention tremor (HP:0002080) | 2.44249225 |
| 53 | Dysmetria (HP:0001310) | 2.43926994 |
| 54 | Gaze-evoked nystagmus (HP:0000640) | 2.43905896 |
| 55 | Hypoplasia of the brainstem (HP:0002365) | 2.43599741 |
| 56 | Hemiplegia (HP:0002301) | 2.42723167 |
| 57 | Gait imbalance (HP:0002141) | 2.42540686 |
| 58 | Vitreoretinal degeneration (HP:0000655) | 2.36140145 |
| 59 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.34637999 |
| 60 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.34637999 |
| 61 | Hyperventilation (HP:0002883) | 2.33557074 |
| 62 | Anxiety (HP:0000739) | 2.33242121 |
| 63 | EEG with generalized epileptiform discharges (HP:0011198) | 2.31394085 |
| 64 | Epileptiform EEG discharges (HP:0011182) | 2.30122102 |
| 65 | Torticollis (HP:0000473) | 2.27193334 |
| 66 | Inappropriate behavior (HP:0000719) | 2.26398256 |
| 67 | Hypsarrhythmia (HP:0002521) | 2.25162494 |
| 68 | Stereotypic behavior (HP:0000733) | 2.24998200 |
| 69 | Impaired smooth pursuit (HP:0007772) | 2.24827576 |
| 70 | Lower limb muscle weakness (HP:0007340) | 2.24503136 |
| 71 | Insomnia (HP:0100785) | 2.24025702 |
| 72 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.23194051 |
| 73 | Scanning speech (HP:0002168) | 2.22371164 |
| 74 | Amyotrophic lateral sclerosis (HP:0007354) | 2.16612684 |
| 75 | Hypoplasia of the corpus callosum (HP:0002079) | 2.13042382 |
| 76 | Polyphagia (HP:0002591) | 2.12799525 |
| 77 | Dysmetric saccades (HP:0000641) | 2.12656566 |
| 78 | Ulnar claw (HP:0001178) | 2.11163750 |
| 79 | Inability to walk (HP:0002540) | 2.10499865 |
| 80 | Spastic tetraplegia (HP:0002510) | 2.08956940 |
| 81 | Aqueductal stenosis (HP:0002410) | 2.08813334 |
| 82 | Pheochromocytoma (HP:0002666) | 2.07465118 |
| 83 | Neuronal loss in central nervous system (HP:0002529) | 2.07296051 |
| 84 | Blue irides (HP:0000635) | 2.07189848 |
| 85 | Amblyopia (HP:0000646) | 2.06577715 |
| 86 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.05691094 |
| 87 | Failure to thrive in infancy (HP:0001531) | 2.03011266 |
| 88 | Intellectual disability, severe (HP:0010864) | 2.01038187 |
| 89 | Hip dysplasia (HP:0001385) | 1.99994948 |
| 90 | Limb dystonia (HP:0002451) | 1.98230411 |
| 91 | Pointed chin (HP:0000307) | 1.97835423 |
| 92 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.96655095 |
| 93 | Open mouth (HP:0000194) | 1.96248277 |
| 94 | Apathy (HP:0000741) | 1.93719030 |
| 95 | Thyroid carcinoma (HP:0002890) | 1.92921960 |
| 96 | Specific learning disability (HP:0001328) | 1.91276827 |
| 97 | Bradykinesia (HP:0002067) | 1.91245203 |
| 98 | Focal dystonia (HP:0004373) | 1.90932386 |
| 99 | Akinesia (HP:0002304) | 1.90708094 |
| 100 | Cutaneous finger syndactyly (HP:0010554) | 1.90470644 |
| 101 | Lower limb amyotrophy (HP:0007210) | 1.90038466 |
| 102 | Abnormality of the astrocytes (HP:0100707) | 1.89388563 |
| 103 | Astrocytoma (HP:0009592) | 1.89388563 |
| 104 | Abnormality of salivation (HP:0100755) | 1.89293937 |
| 105 | Lower limb asymmetry (HP:0100559) | 1.88600060 |
| 106 | Clonus (HP:0002169) | 1.87898427 |
| 107 | Hyperacusis (HP:0010780) | 1.84532236 |
| 108 | Sleep apnea (HP:0010535) | 1.84182586 |
| 109 | Genital tract atresia (HP:0001827) | 1.83105744 |
| 110 | Increased circulating renin level (HP:0000848) | 1.81075936 |
| 111 | Ventricular fibrillation (HP:0001663) | 1.80981572 |
| 112 | Volvulus (HP:0002580) | 1.80590215 |
| 113 | Elfin facies (HP:0004428) | 1.80501849 |
| 114 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.80072110 |
| 115 | Vaginal atresia (HP:0000148) | 1.79450277 |
| 116 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.79378042 |
| 117 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.78662735 |
| 118 | Short 4th metacarpal (HP:0010044) | 1.78662735 |
| 119 | Heterotopia (HP:0002282) | 1.78501366 |
| 120 | Exotropia (HP:0000577) | 1.77951607 |
| 121 | Impaired vibratory sensation (HP:0002495) | 1.77928800 |
| 122 | Status epilepticus (HP:0002133) | 1.76482538 |
| 123 | Aplasia involving bones of the extremities (HP:0009825) | 1.75771474 |
| 124 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.75771474 |
| 125 | Aplasia of the phalanges of the hand (HP:0009802) | 1.75771474 |
| 126 | Congenital primary aphakia (HP:0007707) | 1.75769110 |
| 127 | Prolonged QT interval (HP:0001657) | 1.75232417 |
| 128 | Postural tremor (HP:0002174) | 1.74288172 |
| 129 | Obstructive sleep apnea (HP:0002870) | 1.74037311 |
| 130 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.73927119 |
| 131 | Nephrogenic diabetes insipidus (HP:0009806) | 1.73683324 |
| 132 | Craniofacial dystonia (HP:0012179) | 1.73518156 |
| 133 | Absent speech (HP:0001344) | 1.73227768 |
| 134 | Widely spaced teeth (HP:0000687) | 1.72440332 |
| 135 | Neoplasm of the heart (HP:0100544) | 1.71867904 |
| 136 | Fetal akinesia sequence (HP:0001989) | 1.70920305 |
| 137 | Hammertoe (HP:0001765) | 1.70920266 |
| 138 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.67981595 |
| 139 | Medial flaring of the eyebrow (HP:0010747) | 1.67025670 |
| 140 | Gastroesophageal reflux (HP:0002020) | 1.65462535 |
| 141 | Tented upper lip vermilion (HP:0010804) | 1.64136263 |
| 142 | Esotropia (HP:0000565) | 1.63951614 |
| 143 | Large earlobe (HP:0009748) | 1.63931267 |
| 144 | Chorioretinal atrophy (HP:0000533) | 1.63418947 |
| 145 | Broad ribs (HP:0000885) | 1.62018768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.96812837 |
| 2 | NTRK3 | 3.66112661 |
| 3 | MAP3K9 | 3.50517873 |
| 4 | EPHA4 | 3.22601620 |
| 5 | MAP3K4 | 2.67604707 |
| 6 | MINK1 | 2.33750097 |
| 7 | NTRK2 | 2.33442067 |
| 8 | EPHA3 | 2.16836736 |
| 9 | BCR | 2.14265836 |
| 10 | PRKD3 | 2.07145310 |
| 11 | PAK6 | 2.06198672 |
| 12 | DAPK2 | 2.01001101 |
| 13 | CAMKK1 | 1.81005337 |
| 14 | NTRK1 | 1.79650240 |
| 15 | MAP2K7 | 1.78052323 |
| 16 | SIK2 | 1.71393319 |
| 17 | PHKG2 | 1.69460528 |
| 18 | PHKG1 | 1.69460528 |
| 19 | KSR2 | 1.61014613 |
| 20 | FRK | 1.58773484 |
| 21 | MAPK13 | 1.58651404 |
| 22 | MAP2K4 | 1.52228137 |
| 23 | KSR1 | 1.51837011 |
| 24 | TNIK | 1.50168861 |
| 25 | CDK5 | 1.49521763 |
| 26 | CAMK1G | 1.28935791 |
| 27 | MAP3K2 | 1.26431001 |
| 28 | TYRO3 | 1.25147571 |
| 29 | RET | 1.24039023 |
| 30 | UHMK1 | 1.17001274 |
| 31 | AKT3 | 1.16310006 |
| 32 | PRKCH | 1.14673228 |
| 33 | LMTK2 | 1.13839196 |
| 34 | STK38 | 1.13512327 |
| 35 | TRIM28 | 1.13009219 |
| 36 | SGK494 | 1.12746656 |
| 37 | SGK223 | 1.12746656 |
| 38 | CCNB1 | 1.10890432 |
| 39 | RIPK1 | 1.09186780 |
| 40 | PAK3 | 1.08095259 |
| 41 | PINK1 | 1.07093882 |
| 42 | SGK3 | 1.06826799 |
| 43 | CAMKK2 | 1.05188180 |
| 44 | FGFR2 | 1.04680581 |
| 45 | MAP4K2 | 1.03135749 |
| 46 | PRPF4B | 1.01414258 |
| 47 | SGK2 | 1.00421787 |
| 48 | TRIB3 | 0.98439714 |
| 49 | MARK2 | 0.98077552 |
| 50 | FES | 0.95937291 |
| 51 | CSNK1G2 | 0.93056682 |
| 52 | STK11 | 0.92144367 |
| 53 | PRKCG | 0.91450257 |
| 54 | ERBB3 | 0.91286012 |
| 55 | WNK3 | 0.88797452 |
| 56 | TAOK1 | 0.87609843 |
| 57 | SCYL2 | 0.86883879 |
| 58 | RIPK4 | 0.86714269 |
| 59 | PDGFRA | 0.85758728 |
| 60 | EPHB2 | 0.82884554 |
| 61 | CSNK1G1 | 0.82310714 |
| 62 | LATS2 | 0.82303126 |
| 63 | CSNK1G3 | 0.82035986 |
| 64 | PNCK | 0.79759464 |
| 65 | ALK | 0.77310127 |
| 66 | DYRK1A | 0.77242308 |
| 67 | SGK1 | 0.76946611 |
| 68 | PLK2 | 0.76298331 |
| 69 | CDC42BPA | 0.74907356 |
| 70 | CASK | 0.74887735 |
| 71 | DAPK1 | 0.73833937 |
| 72 | CAMK2A | 0.72383667 |
| 73 | WNK1 | 0.70375745 |
| 74 | CDK15 | 0.68219994 |
| 75 | OXSR1 | 0.67912059 |
| 76 | CDK18 | 0.67275140 |
| 77 | CAMK1D | 0.66833155 |
| 78 | PRKCZ | 0.65225410 |
| 79 | CDK14 | 0.65001739 |
| 80 | STK38L | 0.63715169 |
| 81 | CAMK1 | 0.61890111 |
| 82 | DMPK | 0.60639242 |
| 83 | BRD4 | 0.60620771 |
| 84 | PKN1 | 0.60415268 |
| 85 | FYN | 0.60097544 |
| 86 | GRK5 | 0.59489120 |
| 87 | ICK | 0.59238419 |
| 88 | ERBB2 | 0.57833202 |
| 89 | MAP3K7 | 0.57825095 |
| 90 | YES1 | 0.57438232 |
| 91 | MAP3K5 | 0.57405498 |
| 92 | MAP3K12 | 0.56908142 |
| 93 | RPS6KA2 | 0.56492202 |
| 94 | FER | 0.56437793 |
| 95 | PDK1 | 0.56123601 |
| 96 | CAMK2B | 0.55977852 |
| 97 | DYRK3 | 0.55772025 |
| 98 | PDPK1 | 0.55667413 |
| 99 | RPS6KA3 | 0.55511058 |
| 100 | INSRR | 0.55348279 |
| 101 | MAP3K13 | 0.54863275 |
| 102 | CDK11A | 0.54062690 |
| 103 | PDGFRB | 0.52863117 |
| 104 | PRKCE | 0.52445732 |
| 105 | CSNK1A1L | 0.49703586 |
| 106 | DYRK1B | 0.49520920 |
| 107 | DDR2 | 0.49220389 |
| 108 | PKN2 | 0.48412517 |
| 109 | PRKACB | 0.47903636 |
| 110 | MAPK10 | 0.47734735 |
| 111 | FGFR3 | 0.46117039 |
| 112 | CSNK1D | 0.44849444 |
| 113 | DYRK2 | 0.44617938 |
| 114 | WNK4 | 0.44405425 |
| 115 | PRKAA1 | 0.43997814 |
| 116 | MAP3K6 | 0.43158153 |
| 117 | ROCK1 | 0.42767838 |
| 118 | MUSK | 0.42701261 |
| 119 | CAMK4 | 0.41532860 |
| 120 | BMPR1B | 0.40263110 |
| 121 | RPS6KB1 | 0.39608643 |
| 122 | PRKG1 | 0.39352952 |
| 123 | RPS6KA4 | 0.38734625 |
| 124 | PTK2 | 0.38273824 |
| 125 | HIPK2 | 0.38065169 |
| 126 | CSNK1E | 0.35772458 |
| 127 | MAPK9 | 0.34685106 |
| 128 | LATS1 | 0.32422198 |
| 129 | CDK3 | 0.31918443 |
| 130 | MAPK8 | 0.31665925 |
| 131 | PRKACA | 0.29728624 |
| 132 | ADRBK2 | 0.29265830 |
| 133 | GSK3B | 0.29189443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.79937820 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.50912521 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.35548022 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.30644764 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.20490917 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.18961480 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.13512889 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.11827576 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.11096660 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.08809396 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 1.90365745 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.87209000 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.85573637 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.79481945 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 1.78514668 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.67750718 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.67244720 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.63914147 |
| 19 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.59528648 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56950417 |
| 21 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.55540305 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.53651802 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.49513609 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.48143671 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.41879316 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.40721667 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.39729387 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.37844414 |
| 29 | Axon guidance_Homo sapiens_hsa04360 | 1.32676317 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32038644 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.30211571 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.27532010 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.22635594 |
| 34 | Glioma_Homo sapiens_hsa05214 | 1.21387129 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.20185473 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.19929069 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.18078453 |
| 38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17055001 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13611442 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.12211272 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.11840064 |
| 42 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.06833480 |
| 43 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.03937717 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01683623 |
| 45 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.00730636 |
| 46 | Endometrial cancer_Homo sapiens_hsa05213 | 0.93908844 |
| 47 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93125038 |
| 48 | Melanogenesis_Homo sapiens_hsa04916 | 0.92679865 |
| 49 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.90150477 |
| 50 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85960502 |
| 51 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84869502 |
| 52 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.84230101 |
| 53 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.82311845 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81266796 |
| 55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.81123184 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80646810 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80308999 |
| 58 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79568996 |
| 59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.76950534 |
| 60 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74694721 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74190957 |
| 62 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73919401 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 0.72746794 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72170104 |
| 65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71222807 |
| 66 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.71007358 |
| 67 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.69868047 |
| 68 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68833208 |
| 69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67954846 |
| 70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67844629 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67363942 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66728112 |
| 73 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64575997 |
| 74 | Phototransduction_Homo sapiens_hsa04744 | 0.63101705 |
| 75 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.62946415 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62722562 |
| 77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62696885 |
| 78 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.62506668 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61999268 |
| 80 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60758667 |
| 81 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60420114 |
| 82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59320626 |
| 83 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58776991 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58443326 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.57622562 |
| 86 | Tight junction_Homo sapiens_hsa04530 | 0.56666466 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55999300 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55477514 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54897614 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.54067036 |
| 91 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.51488514 |
| 92 | Adherens junction_Homo sapiens_hsa04520 | 0.50287669 |
| 93 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.50010232 |
| 94 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.49145355 |
| 95 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.48447291 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.47706301 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47482872 |
| 98 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.47338202 |
| 99 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.47219333 |
| 100 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.46117707 |
| 101 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45113321 |
| 102 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44392782 |
| 103 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43812759 |
| 104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43593432 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.43552177 |
| 106 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.43488337 |
| 107 | Melanoma_Homo sapiens_hsa05218 | 0.43148393 |
| 108 | Alcoholism_Homo sapiens_hsa05034 | 0.41825350 |
| 109 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41229418 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40897636 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39369148 |
| 112 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38768395 |
| 113 | Focal adhesion_Homo sapiens_hsa04510 | 0.38372680 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37827074 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.36893136 |

